Juvenile myelomonocytic leukemia is an aggressive neoplasia of early childhood. Only allogeneic stem cell transplantation (SCT) offers a long-term cure. In the absence of an HLA-matched family donor, early SCT from an unrelated donor will be the treatment of choice for most children. With clear evidence of a graft-versus-leukemia effect and a high post-transplant relapse rate, outcome of SCT will depend, in part, on the management of immunosuppression during the procedure. The impact of pretransplant cytoreductive treatment, such as intensive chemotherapy, splenectomy, or 13-cis retinoic acid, is unclear. Hypersensitivity for granulocyte-macrophage colony-stimulating factor and pathologic activation of the Ras/MAPK pathway play an important role in the pathophysiology of juvenile myelomonocytic leukemia and will provide the opportunity for several novel therapy approaches.
Br J Haematol. 2002 Mar;116(3):716-24
[PMID:
11849238]
Nat Genet. 2003 Jun;34(2):148-50
[PMID:
12717436]
Blood. 1997 Dec 15;90(12):4910-7
[PMID:
9389708]
N Engl J Med. 1995 Jun 1;332(22):1520-1; author reply 1521
[PMID:
7739703]
Cancer. 1984 Aug 15;54(4):675-86
[PMID:
6589029]
Blood. 1988 Apr;71(4):1144-6
[PMID:
3281722]
Blood. 2002 Jun 1;99(11):4147-53
[PMID:
12010819]
Blood. 1998 Jul 1;92(1):267-72
[PMID:
9639526]
Blood. 2003 Mar 1;101(5):1713-4
[PMID:
12393482]
Mol Cell. 2000 Jan;5(1):189-95
[PMID:
10678181]
Nat Genet. 1996 Feb;12(2):144-8
[PMID:
8563751]
N Engl J Med. 1994 Dec 22;331(25):1680-4
[PMID:
7605422]
Med Pediatr Oncol. 1990;18(4):311-6
[PMID:
2355891]
Med Pediatr Oncol. 1984;12(1):28-32
[PMID:
6583468]
Bone Marrow Transplant. 2000 Aug;26(4):377-82
[PMID:
10982283]
N Engl J Med. 1997 Jun 12;336(24):1713-20
[PMID:
9180088]
Blood. 1997 May 15;89(10):3534-43
[PMID:
9160658]
Leukemia. 2002 Mar;16(3):376-81
[PMID:
11896541]
Blood. 2000 Jan 15;95(2):639-45
[PMID:
10627474]
Blood. 1977 Apr;49(4):559-62
[PMID:
265178]
Cancer Treat Rep. 1986 Mar;70(3):363-7
[PMID:
3456833]
Blood. 1999 Oct 1;94(7):2469-76
[PMID:
10498620]
Leukemia. 2002 Apr;16(4):645-9
[PMID:
11960345]
J Clin Oncol. 1997 Feb;15(2):566-73
[PMID:
9053478]
Eur J Pediatr. 1989 Jan;148(4):379-80
[PMID:
2707286]
Med Pediatr Oncol. 1993;21(1):73-6
[PMID:
8426579]
J Clin Oncol. 1987 Dec;5(12):1960-7
[PMID:
2445935]
J Clin Oncol. 2002 Jan 15;20(2):434-40
[PMID:
11786571]
Leukemia. 1987 Oct;1(10):730-3
[PMID:
3312835]
Blood. 1998 Jan 1;91(1):365-7
[PMID:
9414312]
Bone Marrow Transplant. 1996 Dec;18(6):1111-6
[PMID:
8971380]
J Pediatr. 1997 Jun;130(6):885-9
[PMID:
9202609]
Leukemia. 1999 Jan;13(1):32-7
[PMID:
10049057]
Med Pediatr Oncol. 1994;22(5):358-9
[PMID:
8127262]
Blood. 1991 Mar 1;77(5):925-9
[PMID:
1704804]
Blood. 2002 Apr 1;99(7):2615-6
[PMID:
11895804]
Leukemia. 1996 Aug;10(8):1269-73
[PMID:
8709630]
Med Pediatr Oncol. 1998 Dec;31(6):516-20
[PMID:
9835905]
Blood. 1998 Dec 1;92(11):4279-86
[PMID:
9834234]
Child, Preschool
Combined Modality Therapy
Hematopoietic Stem Cell Transplantation
Humans
Infant
Leukemia, Myelomonocytic, Acute
Leukemia, Myelomonocytic, Chronic
